SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Revolution Medicines receives FDA review acceptance for daraxonrasib

Revolution Medicines...

RVMD

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.